LfcinB (20–25)
General Information
DCTPep ID DCTPep00794
Peptide Name LfcinB (20–25)
Sequence RRWQWR
Sequence Length 6
UniProt ID Not available
PubChem CID Not available
Origin Bovine Lactoferricin
Type Native peptide
Classification
Cancer therapy related peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
MDA-MB-231 | Breast adenocarcinoma | IC50>203 μM | MTT assay | 2h | 1 |
MDA-MB-468 | Breast adenocarcinoma | IC50>203 μM | MTT assay | 2h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C45H66N18O8
Absent amino acids ACDEFGHIKLMNPSTVY
Theoretical pI 12.30
Acidic residues 0
Basic residues 3
Polar residues 0
Molecular weight (Average) 987.13
Molecular weight (Monoisotopic) 986.53
Common amino acids R
Net charge 3
Instability index (II) 199.27
Aliphatic index 0.00
Grand average of hydropathicity (GRAVY) -3.133
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 11000
Abs 0.1% (=1 g/l) 11.143
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28961215
Title Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines
Year 2017
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available